Aurealis Pharma

Finland
Kuopio, North Savo, Finland, 70210

Company profile

Aurealis Pharma company profile

Aurealis Pharma is a biopharmaceutical company aiming at developing ground-breaking medicines for the treatment of cancer and chronic wounds. They are dedicated in the R&D of gene and cell based therapies, as well as the development of new active molecules by computational modeling of nature derived compounds. Their key strategy is to perform outstanding interdisciplinary R&D and to implement these into new business models. They are actively seeking for collaborations with pharmaceutical companies, academic research institutions and pre-clinical CROs.

Business identity

Phone number
+358458433550
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$1M-$10M
Founded
2010-04-01, Month

Headquarters

Postal code
70210
Country code
FI
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$13.6M
Last funding
Series B / $7.8M / 2019-02-12
Last equity funding
Series B / $7.8M
Investors
3
Lead investors
2
Founders
3

Founders and investors

Founders

Dirk WeberMarkus forsbergThomas wirth

Lead investors

Business FinlandFinnvera Venture Capital

Investors

Business FinlandFinnvera Venture Capital